References

glaucoma

Национальный журнал Глаукома

National Journal glaucoma

2078-41042311-6862

Federal State Budgetary Institution of Science “Krasnov Research Institute of Eye Diseases”

10.53432/2078-4104-2021-20-3-87-101

glaucoma-346

Research Article

ОБЗОР ЛИТЕРАТУРЫ

REVIEW OF LITERATURE

Роль витаминов группы В в предупреждении прогрессирования глаукомной оптической нейропатии

The role of B vitamins in preventing the progression of glaucomatous optic neuropathy

Лоскутов

И. А.

Loskoutov

I. A.

д.м.н., заведующий отделением офтальмологии

129110, Москва, ул. Щепкина, д. 61/2

Dr. Sci. (Med.), Head of the Ophthalmology Department

61/2 Schepkina St., Moscow, 129110

Корнеева

А. В.

Korneeva

A. V.

Корнеева Алина Владимировна, к.м.н., врач-офтальмолог

117463, Москва, Голубинская ул., 16

Cand. Sci. (Med.), Ophthalmologist

16 Golubinskaya St., Moscow, 117463

a-bel@mail.ru

ГБУЗ МО МОНИКИ им. М.Ф. ВладимирскогоРоссияMoscow Regional Research and Clinical Institute ("MONIKI")Russian Federation

АНО «Клиника микрохирургии глаза Взгляд»РоссияANO «Clinic of Eye Microsurgery Vzglyad»Russian Federation

2021

20092021

20387101

2021

Лоскутов И.А., Корнеева А.В.

Loskoutov I.A., Korneeva A.V.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.glaucomajournal.ru/jour/article/view/346

В литературном обзоре обсуждается роль витаминов (особенно витаминов группы В) в обеспечении нейропротекторной и антиоксидантной защиты сетчатки при глаукомной оптической нейропатии. Приводятся данные зарубежных исследований, посвященных изучению положительного влияния витаминов данной группы на состояние ганглиозных клеток сетчатки и аксонов зрительного нерва.

The literature review discusses the role of vitamins (in particular, B vitamins) in maintaining neuroprotective and antioxidant properties of the retina in glaucomatous optic neuropathy, and presents the data from foreign research papers devoted to studying the positive influence of vitamins of this group on the condition of ganglion cells of the retina and axons of the optic nerve.

глаукомная оптическая нейропатиятиаминрибофлавинниацинпиридоксинфолиевая кислотакобаламинфлавоноидынейропротекция

glaucomatous optic neuropathythiamineriboflavinniacinpyridoxinefolic acidcobalaminflavonoidsneuroprotection

References1

Resnikoff S., Pascolini D., Etya'ale D., Kocur I. et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82(11):844–851. doi.org//S0042-96862004001100009

Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90(3):262–267. doi.org/10.1136/bjo.2005.081224

Weinreb R.N., Aung T., Medeiros F.A. The pathophysiology and treatment of glaucoma: A review. JAMA. 2014; 311(18):1901–1911. doi:10.1001/jama.2014.3192

Heijl A., Bengtsson B., Chauhan B.C., Lieberman M.F. et al. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology. 2008; 115(9): 1557–1565. doi:10.1016/j. ophtha.2008.02.005

Gillespie B.W., Musch D.C., Guire K.E., Mills R.P., Lichter P.R., Janz N.K., Wren P.A.; CIGTS (Collaborative Initial Glaucoma Treatment Study) Study Group. The collaborative initial glaucoma treatment study: Baseline visual field and test-retest variability. Invest Ophthalmol Vis Sci. 2003; 44(6):2613–2620. doi:10.1167/iovs.02-0543

Chauhan B.C., Mikelberg F.S., Balaszi A.G., LeBlanc R.P., Lesk M.R., Trope G.E.; Canadian Glaucoma Study Group. Canadian glaucoma study: risk factors for the progression of open-angle glaucoma. Arch Ophthalmol. 2008; 126(8):1030–1036. doi:10.1001/archopht.126.8.1030

Adatia F.A., Damji K.F. Chronic open-angle glaucoma. Review for primary care physicians. Can Fam Physician. 2005; 51(9):1229–1237.

Bagnis A., Papadia M., Scotto R., Traverso C.E. Current and emerging medical therapies in the treatment of glaucoma. Expert Opin Emerg Drugs. 2011; 16(2):293–307. doi:10.1517/14728214.2011.563733

The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998; 126(4):498–505. doi:10.1016/s0002-9394(98)00272-4

Heijl A., Leske M.C., Bengtsson B., Hyman L., Bengtsson B., Hussein M. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002; 120(10):1268–1279. doi:10.1001/archopht.120.10.1268

AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 2002; 134(4):499–512. doi:10.1016/s0002-9394(02)01659-8

Morrone L.A., Rombola L., Adornetto A., Corasaniti M.T., Russo R. Rational basis for nutraceuticals in the treatment of glaucoma. Curr Neuropharmacol. 2017; 16(7):1004–1017. doi:10.2174/1570159X15666171109124520

Soto I., Howell G.R. The complex role of neuroinflammation in glaucoma. Cold Spring Harb Perspect Med. 2014; 4(8): a017269. doi:10.1101/cshperspect.a017269

Križaj D., Ryskamp D.A., Tian N., Tezel G., Mitchell C.H., Slepak V.Z., Shestopalov V.I. From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma. Curr Eye Res. 2014; 39(2):105–119. doi:10.3109/02713683.2013.836541

Yuan L., Neufeld A.H. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia. 2000; 32(1):42–50.

Stringham J.M., Snodderly D.M. Enhancing performance while avoiding damage: a contribution of macular pigment. Invest Opthalmol Vis Sci. 2013; 54(9):6298–6306. doi:10.1167/iovs.13-12365

Coleman A.L., Stone K.L., Kodjebacheva G., Yu F., Pedula K.L., Ensrud K.E., Cauley J.A., Hochberg M.C., Topouzis F., Badala F., Mangione C.M.; Study of Osteoporotic Fractures Research Group.Glaucoma risk and the consumption of fruits and vegetables among older women in the study of osteoporotic fractures. Am J Ophthalmol. 2008; 145(6):1081–1089. doi:10.1016/j.ajo.2008.01.022

Kang J.H., Pasquale L.R., Willett W.C., Rosner B.A., Egan K.M., Faberowski N., Hankinson S.E. Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr. 2004; 79(5):755–764.тdoi:10.1093/ajcn/79.5.755

Ramdas W.D., Wolfs R.C., Kiefte-de Jong J.C., Hofman A., de Jong P.T., Vingerling J.R., Jansonius N.M. Nutrient intake and risk of open-angle glaucoma: the Rotterdam Study. Eur J Epidemiol. 2012; 27(5):385–393. doi:10.1007/s10654-012-9672-z

Renard J.P., Rouland J.F., Bron A., Sellem E., Nordmann J.P., Baudouin C., Denis P., Villain M., Chaine G., Colin J., de Pouvourville G., Pinchinat S., Moore N., Estephan M., Delcourt C. Nutritional, lifestyle and environmental factors in ocular hypertension and primary openangle glaucoma: an exploratory case-control study. Acta Ophthalmol. 2013; 91(6):505–513. doi:10.1111/j.1755-3768.2011.02356.x

Wang S.Y., Singh K., Lin S.C. Glaucoma and vitamins A, C, and E supplement intake and serum levels in a population-based sample of the United States. Eye (Lond). 2013; 27(4):487–494. doi:10.1038/eye.2013.10

Kang J.H., Pasquale L.R., Willett W., Rosner B., Egan K.M., Faberowski N., Hankinson S.E. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol. 2003; 158(4):337–346. doi:10.1093/aje/kwg167

Li S., Li D., Shao M., Cao W., Sun X. Lack of association between serum vitamin B6, vitamin B12, and vitamin D levels with different types of glaucoma: A systematic review and meta-analysis. Nutrients. 2017; 9(6):636. doi:10.3390/nu9060636

Izzotti A., Saccà S.C., Cartiglia C., De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med. 2003; 114(8):638–646. doi:10.1016/s0002-9343(03)00114-1

Saccà S.C., Pascotto A., Camicione P., Capris P., Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol. 2005; 123(4):458–463. doi:10.1001/archopht.123.4.458

Ganapathy P.S., White R.E., Ha Y., Bozard B.R., et al. The role of N-methyl-Daspartate receptor activation in homocysteine-induced death of retinal ganglion cells. Invest Ophthalmol Vis Sci. 2011; 52(8):5515–5524. doi:10.1167/iovs.10-6870

Engin K.N. Alpha-tocopherol: looking beyond an antioxidant. Mol Vis. 2009; 15:855–860.

Ritch R. Neuroprotection: Is it already applicable to glaucoma therapy? Curr Opin Ophthalmol. 2000; 11(2):78–84. doi:10.1097/00055735-200004000-00002

Himori N., Kunikata H., Shiga Y., Omodaka K., Maruyama K., Takahashi H., Nakazawa T. The association between systemic oxidative stress and ocular blood flow in patients with normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2016; 254(2):333–341. doi:10.1007/s00417-015-3203-z

Mares J.A. High-dose antioxidant supplementation and cataract risk. Nutr Rev. 2004; 62(1):28–32. doi:10.1111/j.1753-4887.2004.tb00003.x

Evans J. Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye (Lond). 2008; 22(6):751–760. doi:10.1038/eye.2008.100

Asregadoo E.R. Blood levels of thiamine and ascorbic acid in chronic open-angle glaucoma. Ann Ophthalmol. 1979; 11(7): 1095–1100.

Giaconi J.A., Yu F., Stone K.L., Pedula K.L., Ensrud K.E., Cauley J.A., Hochberg M.C., Coleman A.L.; Study of Osteoporotic Fractures Research Group. The association of consumption of fruits/vegetables with decreased risk of glaucoma among older African-American women in the study of osteoporotic fractures. Am J Ophthalmol. 2012; 154(4):635–644. doi:10.1016/j.ajo.2012.03.048

Jung K.I., Kim Y.C., Park C.K. Dietary niacin and open-angle glaucoma: the korean national health and nutrition examination survey. Nutrients. 2018; 10(4):387. doi:10.3390/nu10040387

Williams P.A., Harder J.M., Foxworth N.E., Cochran K.E., Philip V.M., Porciatti V., Smithies O., John S.W. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017; 355(6326):756–760. doi:10.1126/science.aal0092

Cui X., Chopp M., Zacharek A., Roberts C., Buller B., Ion M., Chen J. Niacin treatment of stroke increases synaptic plasticity and axon growth in rats. Stroke. 2010; 41:2044–2049. doi:10.1161/STROKEAHA.110.589333

Kaplon R.E., Gano L.B., Seals D.R. Vascular endothelial function and oxidative stress are related to dietary niacin intake among healthy middle-aged and older adults. J Appl Physiol (1985). 2014; 116(2):156–163. doi:10.1152/japplphysiol.00969.2013

Graff E.C., Fang H., Wanders D., Judd R.L. Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. Metabolism. 2016; 65(2):102–113. doi:10.1016/j.metabol.2015.10.001

Kerr J.S., Adriaanse B.A., Greig N.H., Mattson M.P., Cader M.Z., Bohr V.A., Fang E.F. Mitophagy and Alzheimer's disease: cellular and molecular mechanisms. Trends Neurosci. 2017; 40(3):151–166. doi:10.1016/j.tins.2017.01.002

Liu D., Pitta M., Jiang H., Lee J.H., Zhang G., Chen X., Kawamoto E.M., Mattson M.P. Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession. Neurobiol Aging. 2013; 34(6):1564–1580. doi:10.1016/j.neurobiolaging.2012.11.020

Wang X., Hu X., Yang Y., Takata T., Sakurai T. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death. Brain Res. 2016; 1643:1–9. doi:10.1016/j.brainres.2016.04.060

Gasperi V., Sibilano M., Savini I., Catani M.V. Niacin in the central nervous system: an update of biological aspects and clinical applications. Int J Mol Sci. 2019; 20(4):974. doi:10.3390/ijms20040974

Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 1994; 38:S3–S6. doi:10.1016/0039-6257(94)90041-8

Drance S., Anderson D.R., Schulzer M.; Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001; 131(6):699–708. doi:10.1016/s0002-9394(01)00964-3

Henry E., Newby D.E., Webb D.J., O’Brien C. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci. 1999; 40(8): 1710–1714.

Henry E., Newby D.E., Webb D.J., O’Brien C. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci.1999; 40(8): 1710–1714.

Buckley C., Hadoke P.W., Henry E., O’Brien C. Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br J Ophthalmol. 2002; 86(2): 227–232. doi:10.1136/bjo.86.2.227

Ebadi M. Regulation and function of pyridoxal phosphate in CNS. Neurochem Int. 1981; 3(3–4):181–205. doi:10.1016/0197-0186(81)90001-2

Miller N.R., Newman N.J. Walsh & Hoyt’s Clinical Neuro-Ophthalmology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 1997.

Albert D.M., Jakobiec F.A., Azar D.T., Gragoudas E.S. Principles and Practice of Ophthalmology. 2nd ed. Philadelphia, W. B. Saunders Company; 2000. doi:org/10.1016/S0039-6257(00)00166-1

Sugiyama T. Coexisting normal-tension glaucoma and deficiencies of folic acid and vitamin B6 (Pyridoxal). Int J Ophthalmol Clin Res. 2015; 2:5. doi:10.23937/2378-346X/1410037

Chisholm I.A. Serum cobalamin and folate in the optic neuropathy associated with tobacco smoking. Can J Ophthalmol. 1978; 13:105–109.

Knox D.L., Chen M.F., Guilarte T.R., Dang C.V., Bumette J. Nutritional amblyopia: folic acid, vitamin B12, and other vitamins. Retina. 1982; 2(4):288–293.

Golnik K.C., Schaible E.R. Folate-responsive optic neuropathy. J Neuroophtalmol. 1994; 14(3):163–169.

Hsu C.T., Miller N.R., Wray M.L. Optic neuropathy from folic acid deficiency without alcohol abuse. Opthalmologica. 2002; 216:65–67. doi:10.1159/000048300

de Silva P., Jayamanne G., Bolton R. Folic acid deficiency optic neuropathy: a case report. J Med Case Rep. 2008; 2:299. doi:10.1186/1752-1947-2-299

Kesler A., Pianka P. Toxic optic neuropathy. Curr Neurol Neurosci Rep. 2003; 3(5):410–414. doi:10.1007/s11910-003-0024-y

Santandrea E., Sani I., Morbioli G., Multari D., Marchini G., Chelazzi L. Optic nerve degeneration and reduced contrast sensitivity due to folic acid deficiency: a behavioral and electrophysiological study in rhesus monkeys. Invest Ophthalmol Vis Sci. 2018; 59(15):6045–6056.doi:10.1167/iovs.18-24822

McCully K.S. Homocysteine, vitamins, and vascular disease prevention. Am J Clin Nutr. 2007; 86(5):1563S–1568S. doi:10.1093/ajcn/86.5.1563S

Roedl J.B., Bleich S., Reulbach U., von Ahse N., Schlötzer-Schrehardt U., Rejdak R., Naumann G.O.H., Kruse F.E., Kornhuber J., Jünemann A.G.M. Homocysteine levels in aqueous humor and plasma of patients with primary open-angle glaucoma. J Neural Transm. 2007; 114(4):445–450. doi:10.1007/s00702-006-0556-9

Xu F., Zhang L., Li M. Plasma homocysteine, serum folic acid, serum vitamin B12, serum vitamin B6, MTHFR and risk of pseudoexfoliation glaucoma: A meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2012; 250(7):1067–1074. doi:10.1007/s00417-011-1877-4

Kang J.H., Loomis S.J., Wiggs J.L., Willett W.C., Pasquale L.R. A prospective study of folate, vitamin B6, and vitamin B12 intake in relation to exfoliation glaucoma or suspected exfoliation glaucoma. JAMA Ophthalmol. 2014; 132(5):549–559. doi:10.1001/jamaophthalmol.2014.100

Fenech M. Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity. Mutat Res. 2012; 733(1–2):21–33. doi:10.1016/j.mrfmmm.2011.11.003

Chan W., Almasieh M., Catrinescu M.M., Levin L.A. Cobalamin-associated superoxide scavenging in neuronal cells is a potential mechanism for vitamin b12-deprivation optic neuropathy. Am J Pathol. 2018; 188(1):160–172. doi:10.1016/j.ajpath.2017.08.032

Anand O.P., Choudhary S.K., Gupta S. Vitamin B12 deficiency induced optic neuropathy. Delhi J Ophthalmol. 2019; 29;125–126. doi:http://dx.doi.org/10.7869/djo.467

Larner A.J. Visual failure caused by vitamin B12 defciency optic neuropathy. Int J Clin Pract. 2004; 58(10):977–978. doi:10.1111/j.1368-5031.2004.00306.x

Chavala S.H., Kosmorsky G.S., Lee M.K., Lee M.S. Optic neuropathy in vitamin B12 defciency. Eur J Intern Med. 2005; 16(6):447–448. doi:10.1016/j.ejim.2005.01.021

Pineles S.L., Avery R.A., Liu G.T. Vitamin B12 optic neuropathy in autism. Pediatrics. 2010; 126(4):e967–970. doi:10.1542/peds.2009-2975

Chu C., Scanlon P. Vitamin B12 deficiency optic neuropathy detected by asymptomatic screening. BMJ Case Rep. 2011; 2011: bcr0220113823. doi:10.1136/bcr.02.2011.3823

Jalil A., Usmani H.A., Khan M.I., Blakely E.L., Taylor R.W., Vassallo G., Ashworth J. Bilateral paediatric optic neuropathy precipitated by vitamin B12 defciency and a novel mitochondrial DNA mutation. Int Ophthalmol. 2013; 33(6):687–690. doi:10.1007/s10792-013-9773-z

Sawicka-Pierko A., Obuchowska I., Hady R.H., Mariak Z., Dadan J. Nutritional optic neuropathy following bariatric surgery. Wideochir Inne Tech Maloinwazyjne. 2014; 9(4):662–666. doi:10.5114/wiitm.2014.47262

Wadia N.H., Desai M.M., Quadros E.V., Dastur D.K. Role of vegetarianism, smoking, and hydroxocobalamin in optic neuritis. Br Med J. 1972; 3:264–267.

Chester E.M., Agamanolis D.P., Harris J.W., Victor M., Hines J.D., Kark J.A. Optic atrophy in experimental vitamin B12 deficiency in monkeys. Acta Neurol Scand. 1980; 61(1):9–26. doi:10.1111/j.1600-0404.1980.tb02991.x

Sadun A.A. Metabolic optic neuropathies. Semin Ophthalmol. 2002; 17(1):29–32. doi:10.1076/soph.17.1.29.10290

Турушева А.В., Моисеева И.Е. Недостаточность питания в пожилом и старческом возрасте. Российский семейный врач. 2019;23(1):5–15. doi:10.17816/RFD201915-15

Turusheva A.V., Moiseeva I.E. Malnutrition in the elderly and old age. Russian Family Doctor. 2018; 23(1):5-15. doi:10.17816/RFD201915-15

Iwakawa H., Nakamura Y., Fukui T., Fukuwatari T., Ugi S., Maegawa H., Doi Y., Shibata K. Concentrations of water-soluble vitamins in blood and urinary excretion in patients with diabetes mellitus. Nutr Metab Insights. 2016; 9:85–92. doi:10.4137/NMI.S40595

Larner A.J. Visual failure caused by vitamin B12 defi ciency optic neuropathy. Int J Clin Pract. 2004; 58(10):977–978. doi:10.1111/j.1368-5031.2004.00306.x

Türkyılmaz K., Öner V., Türkyılmaz A.K., Kırba¸s A., Kırba¸s S., ¸Sekeryapan B. Evaluation of peripapillary retinal nerve fiber layer thickness in patients with vitamin B12 deficiency using spectral domain optical coherence tomography. Curr Eye Res. 2013; 38(6):680–684. doi:10.3109/02713683.2012.758291

Earnest C.P., Wood K.A., Church T.S. Complex multivitamin supplementation improves homocysteine and resistance to LDL-C oxidation. J Am Coll Nutr. 2003; 22(5):400–407. doi:10.1080/07315724.2003.10719323

Flynn M.A., Irvin W., Krause G. The effect of folate and cobalamin on osteoarthritic hands. J Am Coll Nutr. 1994; 13(4):351–356. doi:10.1080/07315724.1994.10718421

Greenberg S.S., Xie J., Zatarain J.M., Kapusta D.R., Miller M.J. Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxininduced hypotension and mortality in rodents: role of nitric oxide. J Pharmacol Exp Ther. 1995; 273(1):257–265. doi:10.1080/07315724.1994.10718421

Crocket J.A. Cyanocobalamin in asthma. Acta Allergol. 1957; 11(4):261–268. doi:10.1111/j.1398-9995.1957.tb03037.x

Miller J.W. Vitamin B12 deficiency, tumor necrosis factor-alpha, and epidermal growth factor: a novel function for vitamin B12? Nutr Rev. 2002; 60(5 Pt 1):142–144. doi:10.1301/00296640260093805

Volkov I., Rudoy I., Press Y. Successful treatment of chronic erythema nodosum with vitamin B12. J Am Board Fam Pract. 2005; 18(6):567–569. doi:10.3122/jabfm.18.6.567

Wheatley C. A scarlet pimpernel for the resolution of inflammation? The role of supratherapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. Med Hypotheses. 2006; 67(1): 124–142. doi:10.1016/j.mehy.2006.01.036

Yamashiki M., Nishimura A., Kosaka Y. Effects of methylcobalamin (vitamin B12) on in vitro cytokine production of peripheral blood mononuclear cells. J Clin Lab Immunol. 1992; 37(4):173–182.

Bagli E., Goussia A., Moschos M.M., Agnantis N., Kitsos G. Natural compounds and neuroprotection: mechanisms of action and novel delivery systems. In Vivo. 2016; 30(5):535–547.

Vohra R., Tsai J.C., Kolko M. The role of inflammation in the pathogenesis of glaucoma. Surv Ophthalmol. 2013; 58(4):311–320. doi:10.1016/j.survophthal.2012.08.010

Agudo M., Perez-Marin M.C., Sobrado-Calvo P., Lönngren U. et al. Immediate upregulation of proteins belonging to different branches of the apoptotic cascade in the retina after optic nerve transection and optic nerve crush. Invest Opthalmol Vis Sci. 2009; 50(1):424–431. doi:10.1167/iovs.08-2404

Chang E.E., Goldberg J.L. Glaucoma 2.0: Neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology. 2012; 119(5):979–986. doi:10.1016/j.ophtha.2011.11.003

Chang E.E., Goldberg J.L. Glaucoma 2.0: Neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology. 2012; 119(5): 979–986. doi:10.1016/j.ophtha.2011.11.003

Pescosolido N., Librando A. Oral administration of an association of forskolin, rutin and vitamins B1 and B2 potentiates the hypotonising effects of pharmacological treatments in POAG patients. Clin Ter. 2010; 161(3):e81-85.

Sisto D., Lavermicocca N., Errico D., Rusciano D. Oral administration of forskolin and rutin contributes to reduce intraocular pressure and improve PERG (pattern electroretinogram) amplitude in glaucomatous patients. JSM Biotechnol Biomed Eng. 2014; 2(1):1036.

Vetrugno M., Uva M.G., Russo V., Iester M., Ciancaglini M., Brusini P., Centofanti M., Rossetti L.M. Oral administration of forskolin and rutin contributes to intraocular pressure control in primary open-angle glaucoma patients under maximum tolerated medical therapy. J Ocul Pharmacol Ther. 2012; 28(5):536–541. doi:10.1089/jop.2012.0021

Mutolo M.G., Albanese G., Rusciano D., Pescosolido N. Oral administration of Forskolin, Homotaurine, Carnosine, and Folic Acid in patients with primary open angle glaucoma: changes in intraocular pressure, pattern electroretinogram amplitude, and foveal sensitivity. J Ocul Pharmacol Ther. 2016; 32(3):178–183. doi:10.1089/jop.2015.0121

Wan M.J., Daniel S., Kassam F., Mutti G., Butty Z., Kasner O., Trope G.E., Buys Y.M. Survey of complementary and alternative medicine use in glaucoma patients. J Glaucoma. 2010; 21(2):79–82. doi:10.1097/IJG.0b013e3182027c0c

Belmonte A., Tormo C., Lopez N., Villalba C., Fernandez C., Hernandez F. Vitamins A, E, B12 and folate levels in different types of glaucoma. Clin Chem Lab Med. 2011; 49:S816.

Lopez-Riquelme N., Villalba C., Tormo C., Belmonte A., Fernandez C., Torralba G., Hernandez F. Endothelin-1 levels and biomarkers of oxidative stress in glaucoma patients. Int Ophthalmol. 2015; 35(4): 527–532. doi:10.1007/s10792-014-9979-8

Cumurcu T., Sahin S., Aydin E. Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma. BMC Ophthalmol.2006; 6:6. doi:10.1186/1471-2415-6-6

Xu F., Zhao X., Zeng S.-M., Li L., Zhong H.-B., Li M. Homocysteine, B vitamins, methylenetetrahydrofolate reductase gene, and risk of primary open-angle glaucoma: a meta-analysis. Ophthalmology. 2012; 119(12):2493–2499. doi:10.1016/j.ophtha.2012.06.025

Li J., Xu F., Zeng R., Gong H., Lan Y. Plasma homocysteine, serum folic acid, serum vitamin B12, serum vitamin B6, MTHFR, and risk of normal-tension glaucoma. J Glaucoma. 2016; 25:e94–e98. doi:10.1097/IJG.0000000000000269

100

Сui X., Xiang J., Zhu W., Wei A., Le Q., Xu J., Zhou X. Vitamin A palmitate and carbomer gel protects the conjunctiva of patients with long-term prostaglandin analogs application. J Glaucoma. 2016; 25(6):487–492. doi:10.1097/IJG.0000000000000316

101

Yuki K., Murat D., Kimura I., Ohtake Y., Tsubota K. Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2010; 248(2):243–248. doi:10.1007/s00417-009-1183-6

102

Ramdas W.D., Schouten J.S.A.G., Webers C.A.B. The effect of vitamins on glaucoma: a systematic review and meta-analysis. Nutrients. 2018; 10(3):359. doi:10.3390/nu10030359

103

Gye H.J., Kim J.M., Yoo C., Shim S.H., Won Y.S., Sung K.C., Lee M.Y., Park K.H. Relationship between high serum ferritin level and glaucoma in a South Korean population: The Kangbuk Samsung health study. Br J Ophthalmol. 2016; 100(12):1703–1707. doi:10.1136/bjophthalmol-2015-307678

104

Krefting E.A., Jorde R., Christoffersen T., Grimnes G. Vitamin D and intraocular pressure — results from a case-control and an intervention study. Acta Ophthalmol. 2014; 92(4):345–349. doi:10.1111/aos.12125

105

Engin K.N., Engin G., Kucuksahin H., Oncu M., Engin G., Guvener B. Clinical evaluation of the neuroprotective effect of alpha-tocopherol against glaucomatous damage. Eur J Ophthalmol. 2007; 17(4):528–533. doi:10.1177/112067210701700408

106

Saccà S.C., Gandolfi S., Bagnis A., Manni G., Damonte G., Traverso C.E., Izzotti A. The outflow pathway: a tissue with morphological and functional unity. J Cell Physiol. 2016; 231(9):1876–1893. doi:10.1002/jcp.25305

The authors declare that there are no conflicts of interest present.